Silence Therapeutics plc, a biotechnology company committed to transforming peoples’ lives by “silencing” diseases through precision engineered medicines, will receive a $2.0 million cash payment from Hansoh Pharmaceutical Group Company Limited following the achievement of a second undisclosed milestone related to the first target under the collaboration.   “This represents an important milestone in our efforts to advance this program into the clinic with Hansoh,” said Craig Tooman, President ...